TEMOZOLOMIDE 180 mg Pill - brown & white capsule/oblong, 22mm
Pill with imprint TEMOZOLOMIDE 180 mg is Brown & White, Capsule/Oblong and has been identified as Temozolomide 180 mg. It is supplied by Mayne Pharma US.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEMOZOLOMIDE 180 mg
Temozolomide
- Imprint
- TEMOZOLOMIDE 180 mg
- Strength
- 180 mg
- Color
- Brown & White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mayne Pharma US
- Manufacturer
- IDT Australia Limited
- National Drug Code (NDC)
- 51862-0087 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
sodium starch glycolate type A potato,
silicon dioxide,
stearic acid,
tartaric acid,
gelatin,
methylparaben sodium,
propylparaben sodium,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Yellow No. 6,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "TEMOZOLOMIDE 180 mg"
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
